Volume 6 Issue 5, May 2021

ISSN: 2095-9907 

EISSN: 2059-23635 

2023 impact factor 40.8 

 (Clarivate Analytics, 2024)
Volume 6 Issue 5, May 2021:
Research Highlight
FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
Xuemei He,Manni Wang &Min Wu  ORCID: orcid.org/0000-0003-1205-982X